Tiffany Guilleminot
Overview
Explore the profile of Tiffany Guilleminot including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
299
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Faure-Bardon V, Bouazza N, Benaboud S, Foissac F, Rouillon S, Froelicher-Bournaud L, et al.
J Antimicrob Chemother
. 2025 Jan;
80(3):760-766.
PMID: 39810739
Background: In cases of maternal primary infection with cytomegalovirus (CMV-MPI) maternal treatment with oral valaciclovir 8 g/day has been shown to reduce the risk of fetal infection. The pharmacological profile...
2.
Veyrenche N, Fourgeaud J, Burgard M, Allali S, Toubiana J, Pinhas Y, et al.
J Infect
. 2025 Jan;
90(2):106409.
PMID: 39761699
Background: A Parvovirus B19 (B19V) outbreak has been reported in Europe in 2023-2024. The aims of this study were 1) to describe the incidence of primary cases from 2012 to...
3.
Bourgon N, Lopez R, Fourgeaud J, Guilleminot T, Bussieres L, Magny J, et al.
J Antimicrob Chemother
. 2024 Aug;
79(10):2500-2508.
PMID: 39087737
Background: The treatment of congenital cytomegalovirus (CMV) infection is usually administered to neonates after birth; however, it can be anticipated during the prenatal period by treating pregnant women in order...
4.
Fourgeaud J, Magny J, Couderc S, Garcia P, Maillotte A, Benard M, et al.
Pediatrics
. 2024 Mar;
153(4).
PMID: 38487823
Background: Approximately 20% of neonates with congenital cytomegalovirus (cCMV) develop long-term sequelae. The ability to accurately predict long-term outcomes as early as the neonatal period would help to provide for...
5.
Fourgeaud J, Nguyen C, Guilleminot T, Ville Y, Leruez-Ville M
J Clin Virol
. 2023 Nov;
169:105614.
PMID: 37982548
Introduction: CMV serology screening in the first trimester pregnancy is based on IgG and IgM testing followed by IgG avidity in cases with positive IgM. However, the sensitivity of this...
6.
Bourgon N, Fitzgerald W, Aschard H, Magny J, Guilleminot T, Stirnemann J, et al.
Viruses
. 2022 Oct;
14(10).
PMID: 36298700
Background: Congenital cytomegalovirus (cCMV) infection is frequent and potentially severe. The immunobiology of cCMV infection is poorly understood, involving cytokines that could be carried within or on the surface of...
7.
Fourgeaud J, Magny J, Couderc S, Garcia P, Maillotte A, Benard M, et al.
J Pediatr
. 2022 Oct;
253:197-204.e5.
PMID: 36181870
Objective: To evaluate cytomegalovirus (CMV) viral load dynamics in blood and saliva during the first 2 years of life in symptomatic and asymptomatic infected infants and to identify whether these...
8.
Delaunay-Moisan A, Guilleminot T, Semeraro M, Briand N, Bader-Meunier B, Berthaud R, et al.
Environ Microbiol
. 2022 Sep;
24(10):4725-4737.
PMID: 36065993
SARS-CoV-2 diagnosis is a cornerstone for the management of coronavirus disease 2019 (COVID-19). Numerous studies have assessed saliva performance over nasopharyngeal sampling (NPS), but data in young children are still...
9.
Sichitiu J, Bourgon N, Guilleminot T, Bessieres B, Leruez-Ville M, Ville Y
Am J Obstet Gynecol MFM
. 2022 Aug;
4(6):100703.
PMID: 35931366
SARS-CoV-2-related placentitis shows distinctive histologic characteristics, and its impact on perinatal outcomes is increasingly under scrutiny. We present two such cases in the third trimester displaying mild maternal clinical symptoms...
10.
Fourgeaud J, Boithias C, Walter-Nicolet E, Kermorvant E, Couderc S, Parat S, et al.
Pediatr Infect Dis J
. 2022 Jan;
41(6):478-481.
PMID: 35093998
Background: Cytomegalovirus (CMV) is the most frequent cause of congenital infection and ≈20% of all infected neonates present or will develop sensorineural hearing loss. Targeted congenital CMV (cCMV) screening in...